Clinical Trials Logo

Seizures, Epileptic clinical trials

View clinical trials related to Seizures, Epileptic.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05518578 Recruiting - Epilepsy Clinical Trials

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

Start date: February 7, 2023
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures

NCT ID: NCT04076449 Recruiting - Epilepsy Clinical Trials

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

CRESS
Start date: September 3, 2019
Phase:
Study type: Observational

Cerebral cavernous malformation (CCM)-related epilepsy (CRE) impairs the quality of life in patients with CCM. Patients could not always achieve seizure freedom after surgical resection of the lesion, suggesting an inadequate treatment and evaluation of the epileptogenic zone or network. Iron deposition in cerebral cavernous malformations has been postulated to play an important role in triggering CRE. Quantitative susceptibility mapping (QSM), as an optimal in vivo imaging technique to quantify iron deposition, is employed to analyze the iron quantity in CCM patients with epilepsy and further combined with brain structural and connectome analysis, to describe the difference between CCMs with and without epilepsy. In vivo biomarkers predicting CRE risk in CCM natural history and CRE control outcome after CCM surgical resection will be further identified to improve management strategy.